Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

J Wu J, Wade SW, Itani T, Castaigne JG, et al. Unmet needs in relapsed/refractory mantle cell lymphoma (r/r MCL) post-covalent Bruton tyrosine kinase inhibitor (BTKi): a systematic literature review and meta-analysis. Leuk Lymphoma 2024 Jul 8:1-14. doi: 10.1080/10428194.2024.2369653.
PMID: 38975903


Privacy Policy